News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,155 Results
Type
Article (88979)
Company Profile (555)
Press Release (796602)
Multimedia
Podcasts (248)
Webinars (36)
Section
Business (267084)
Career Advice (4166)
Deals (40033)
Drug Delivery (182)
Drug Development (91801)
Employer Resources (208)
FDA (18610)
Job Trends (17500)
News (398934)
Policy (40026)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3065)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (246)
Alzheimer's disease (2048)
Antibody-drug conjugate (ADC) (597)
Approvals (19017)
Artificial intelligence (933)
ASCO (345)
Autoimmune disease (389)
Automation (70)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (262)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (87)
Breast cancer (868)
Cancer (6864)
Cardiovascular disease (582)
Career advice (3603)
Career pathing (54)
CAR-T (398)
CDC (77)
Celiac Disease (3)
Cell therapy (1115)
Cervical cancer (60)
Clinical research (79473)
Collaboration (2492)
Commercialization (1)
Company closure (8)
Compensation (1613)
Complete response letters (116)
COVID-19 (3046)
CRISPR (130)
C-suite (1380)
Cystic fibrosis (170)
Data (9089)
Decentralized trials (3)
Denatured (95)
Depression (207)
Dermatology (107)
Diabetes (736)
Diagnostics (7671)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (474)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (335)
Earnings (102642)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139086)
Executive appointments (1238)
FDA (22927)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2039)
Gene editing (285)
Generative AI (95)
Gene therapy (878)
GLP-1 (1306)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21278)
Hematology (198)
HIV (103)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (370)
Immuno-oncology (124)
Indications (229)
Infectious disease (3459)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (339)
Interviews (823)
IPO (18020)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (129)
Layoffs (698)
Leadership (55)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (907)
Lymphoma (494)
Machine learning (70)
Management (68)
Manufacturing (1321)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15328)
Medtech (15531)
Mergers & acquisitions (23391)
Metabolic disorders (1894)
mRNA (283)
Multiple sclerosis (214)
NASH (24)
Neurodegenerative disease (547)
Neuropsychiatric disorders (133)
Neuroscience (3890)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5149)
Now hiring (84)
Obesity (897)
Opinion (383)
Ovarian cancer (255)
Pain (297)
Pancreatic cancer (377)
Parkinson's disease (433)
Partnered (43)
Patents (699)
Patient recruitment (843)
Peanut (72)
People (68252)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24553)
Phase 2 (34519)
Phase 3 (25957)
Pipeline (10565)
Policy (408)
Postmarket research (3561)
Preclinical (11014)
Press Release (72)
Prostate cancer (362)
Psychedelics (79)
Radiopharmaceuticals (383)
Rare diseases (1348)
Real estate (7465)
Recruiting (82)
Regulatory (30763)
Reports (78)
Research institute (2780)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (253)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (151)
Tariffs (104)
The Weekly (150)
Vaccines (1340)
Venture capital (143)
Weight loss (608)
Women's health (148)
Worklife (25)
Date
Today (35)
Last 7 days (516)
Last 30 days (2002)
Last 365 days (33334)
2026 (18781)
2025 (33214)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1298)
Alabama (103)
Alaska (7)
Arizona (413)
Arkansas (16)
Asia (52490)
Australia (9225)
California (14820)
Canada (4166)
China (1678)
Colorado (638)
Connecticut (653)
Delaware (456)
Europe (121038)
Florida (2229)
Georgia (482)
Hawaii (4)
Idaho (70)
Illinois (1298)
India (112)
Indiana (679)
Iowa (25)
Japan (634)
Kansas (145)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1777)
Massachusetts (10842)
Michigan (430)
Minnesota (825)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3925)
New Mexico (35)
New York (3912)
North Carolina (1961)
North Dakota (11)
Northern California (7407)
Ohio (462)
Oklahoma (29)
Oregon (46)
Pennsylvania (2899)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (92)
South Dakota (2)
Southern California (5852)
Tennessee (241)
Texas (2406)
United States (52904)
Utah (444)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1203)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 886,155 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq
Eighteen companies have gone public this year so far, putting 2026 on pace to record the highest number of IPOs since the pandemic-driven high of 2021.
July 20, 2026
·
2 min read
·
Tristan Manalac
IgA nephropathy
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
The FDA is currently reviewing Vertex Pharmaceuticals’ povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from campaigns from Novartis and Vera Therapeutics for their recently approved IgAN therapies Fabhalta and Trutakna.
July 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older
July 20, 2026
·
6 min read
Press Releases
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
July 20, 2026
·
10 min read
Press Releases
Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026
July 20, 2026
·
4 min read
Press Releases
Medtrum Advances 300U Tubeless Patch Pump Toward German Launch
July 20, 2026
·
3 min read
Press Releases
Biovica Receives First Work Order Under Expanded Master Services Agreement with Leading Global Pharmaceutical Customer
July 20, 2026
·
2 min read
Press Releases
Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC
July 20, 2026
·
5 min read
Diabetes
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape with innovative approaches—and experts say there’s room for all of them.
July 20, 2026
·
7 min read
·
Michael Gibney
Cell therapy
How Kyverna rode CAR T’s autoimmune wave to the FDA’s door
Poised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.
July 20, 2026
·
3 min read
·
Annalee Armstrong
1 of 88,616
Next
